COVID-19: Vaccine safety post-market surveillance

COVID-19: Vaccine safety post-market surveillance Canada has several systems in place to monitor the safety and effectiveness of vaccines starting in the early development stage and continuing for as long as the vaccines are in use. Get the facts. Visit Canada.ca/covid-vaccine to learn more. 2021-08-31 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19Vaccine safetypost-market surveillancesurveillancevaccinesvaccine safetyCOVID-19 vaccinevaccine effectivenessCommunity immunityvaccination programscoronavirusCOVIDpandemic COVID-19: Vaccine safety post-market surveillanceHTML https://www.canada.ca/en/public-health/services/video/covid-19-vaccine-safety-post-market-surveillance.html COVID-19: Vaccine safety post-market surveillanceHTML https://www.canada.ca/fr/sante-publique/services/video/covid-19-surveillance-innocuite-vaccins-apres-mise-marche.html COVID-19: Vaccine safety post-market surveillance (described video)HTML https://www.canada.ca/en/public-health/services/video/covid-19-vaccine-safety-post-market-surveillance-described-video.html COVID-19: Vaccine safety post-market surveillance (described video)HTML https://www.canada.ca/fr/sante-publique/services/video/covid-19-surveillance-innocuite-vaccins-apres-mise-marche-video-description.html

Canada has several systems in place to monitor the safety and effectiveness of vaccines starting in the early development stage and continuing for as long as the vaccines are in use. Get the facts. Visit Canada.ca/covid-vaccine to learn more.

Data and Resources

Similar records